Sacituzumab Tirumotecan in Neoadjuvant Treatment of Early-Stage TNBC
Clinical trial NCT07007780 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07007780
- Sponsor
- Xijing Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-20
- Primary completion
- 2026-08-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.